73,638 Axon Enterprise, Inc $AXON Shares Bought by Fulcrum Asset Management LLP

Key Points

• Fulcrum Asset Management bought 73,638 Axon shares in Q3, increasing its stake by 94,407.7% to 73,716 shares, valued at about $31.1 million at quarter-end.
• Axon’s quarterly revenue rose 27.8% year over year to $908.55 million, but fell short of estimates; earnings of $1.72 per share also missed the $1.89 consensus.
• Analysts maintained a consensus “Moderate Buy” rating and a $631.35 price target, although several firms recently lowered their targets.

Fulcrum Asset Management LLP boosted its holdings in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 94,407.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 73,716 shares of the biotechnology company's stock after buying an additional 73,638 shares during the period. Axon Enterprise makes up about 1.4% of Fulcrum Asset Management LLP's investment portfolio, making the stock its 8th largest position. Fulcrum Asset Management LLP owned about 0.09% of Axon Enterprise worth $31,146,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Keating Financial Advisory Services Inc. acquired a new position in Axon Enterprise in the 2nd quarter valued at approximately $31,000. Washington Trust Advisors Inc. grew its holdings in shares of Axon Enterprise by 1,300.0% during the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company's stock worth $39,000 after purchasing an additional 65 shares in the last quarter. M & L Capital Management Ltd acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth approximately $30,000. Wealth Enhancement Trust Services Inc. bought a new stake in shares of Axon Enterprise during the third quarter valued at approximately $33,000. Finally, Delos Wealth Advisors LLC bought a new stake in shares of Axon Enterprise during the second quarter valued at approximately $45,000. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Performance

AXON opened at $313.00 on Monday. The company has a current ratio of 3.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.76. The stock has a market capitalization of $25.43 billion, a PE ratio of 100.32, a PEG ratio of 5.95 and a beta of 1.48. Axon Enterprise, Inc has a 1-year low of $307.00 and a 1-year high of $665.07. The firm has a 50-day moving average price of $441.53 and a two-hundred day moving average price of $475.20.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company had revenue of $908.55 million during the quarter, compared to the consensus estimate of $934.33 million. During the same period in the prior year, the firm posted $1.17 earnings per share. The company's revenue was up 27.8% on a year-over-year basis. As a group, equities analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, insider Isaiah Fields sold 1,017 shares of the company's stock in a transaction on Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the transaction, the insider owned 56,264 shares of the company's stock, valued at approximately $27,032,038.80. This represents a 1.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the company's stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 37,397 shares of company stock worth $21,234,034. Company insiders own 4.20% of the company's stock.

Analyst Ratings Changes

AXON has been the subject of a number of recent research reports. Needham & Company LLC dropped their price objective on shares of Axon Enterprise from $750.00 to $500.00 and set a "buy" rating for the company in a research note on Friday. The Goldman Sachs Group decreased their target price on shares of Axon Enterprise from $715.00 to $675.00 and set a "buy" rating on the stock in a research report on Monday, September 21st. Northland Securities set a $540.00 target price on shares of Axon Enterprise in a research note on Friday. Royal Bank Of Canada lowered their target price on shares of Axon Enterprise from $735.00 to $615.00 and set an "outperform" rating on the stock in a research note on Friday. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. Thirteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $631.35.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q3 revenue reached a record $909 million, up 28% year over year, while software and services revenue rose 43%. Axon also reported AI annual recurring revenue above $100 million, signaling continued demand for its software and AI offerings. Axon Q3 results
• Neutral Sentiment: Axon committed an additional $1.2 billion to drone maker Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The move could expand Axon’s Drone as First Responder business, but its scale also raises investment and execution risks. Reuters: Axon invests in Skydio
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of $908.55 million fell short of analyst expectations. Axon’s 2026 revenue forecast was reduced to $3.6 billion from a consensus of about $3.7 billion; its Q4 revenue guidance also came in below estimates. The company cited delays in federal counter-drone projects, while margin pressure added to concerns. Zacks: Q3 miss and outlook
• Negative Sentiment: Several analysts lowered price targets after the results, and Craig Hallum downgraded AXON from Buy to Hold, adding to pressure on investor sentiment. Benzinga: analyst forecast changes
• Negative Sentiment: A class-action lawsuit over Axon’s license-plate surveillance practices is a potential additional legal and reputational overhang. Class-action announcement

Axon Enterprise Company Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.

The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.

Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.